These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. Jones A J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670 [TBL] [Abstract][Full Text] [Related]
25. Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia. Suzuki H; Gen K; Otomo M; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K Psychiatry Clin Neurosci; 2013 Feb; 67(2):76-82. PubMed ID: 23438159 [TBL] [Abstract][Full Text] [Related]
26. Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison. Fu DJ; Bossie CA; Sliwa JK; Ma YW; Alphs L Int Clin Psychopharmacol; 2014 Jan; 29(1):45-55. PubMed ID: 24113628 [TBL] [Abstract][Full Text] [Related]
27. Paliperidone: quo vadis? Citrome L Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660 [TBL] [Abstract][Full Text] [Related]
28. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Fowler JA; Bettinger TL; Argo TR Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262 [TBL] [Abstract][Full Text] [Related]
29. The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial. Suzuki H; Gen K; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K Int J Psychiatry Clin Pract; 2014 Jan; 18(1):58-62. PubMed ID: 24047427 [TBL] [Abstract][Full Text] [Related]
30. Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia. Chung TS; Lung FW J Clin Psychopharmacol; 2012 Jun; 32(3):394-7. PubMed ID: 22544010 [TBL] [Abstract][Full Text] [Related]
31. Paliperidone overdose in a patient with schizophrenia. Chang JP; Huang CC; Su KP Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588 [No Abstract] [Full Text] [Related]
32. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Li H; Rui Q; Ning X; Xu H; Gu N Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787 [TBL] [Abstract][Full Text] [Related]
33. Risperidone-induced ejaculatory dysfunction: a case report. Kaneda Y Eur Psychiatry; 2001 Mar; 16(2):134-5. PubMed ID: 11311180 [No Abstract] [Full Text] [Related]
34. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent. Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400 [TBL] [Abstract][Full Text] [Related]
35. Practical guidelines on the use of paliperidone palmitate in schizophrenia. Newton R; Hustig H; Lakshmana R; Lee J; Motamarri B; Norrie P; Parker R; Schreiner A Curr Med Res Opin; 2012 Apr; 28(4):559-67. PubMed ID: 22321007 [TBL] [Abstract][Full Text] [Related]
36. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens. Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197 [TBL] [Abstract][Full Text] [Related]
37. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia. Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369 [TBL] [Abstract][Full Text] [Related]
38. Paliperidone in the treatment of Tourette's syndrome with comorbid schizophrenia. Guan CH; Tsai SJ Psychiatry Clin Neurosci; 2013 Feb; 67(2):128. PubMed ID: 23438169 [No Abstract] [Full Text] [Related]
39. Paliperidone use in the elderly. Madhusoodanan S; Zaveri D Curr Drug Saf; 2010 Apr; 5(2):149-52. PubMed ID: 20406162 [TBL] [Abstract][Full Text] [Related]
40. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. Teng PR; Lane HY J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]